ABSTRACT
Ophthalmic examination is essential in the avian triage process in order to apply prompt therapeutic plans and evaluate rehabilitation potential. Fundoscopy is traditionally performed by direct or indirect ophthalmoscopy. Recent technological developments have enabled the design of a small-sized and affordable retinal imaging system to examine the fundus. We investigate the use of a smartphone-based device to realize fundus examination through a prospective cross-sectional observational study. Seventy-seven eyes of 39 birds of 15 different species were evaluated using the smartphone-based device in a rescue wildlife center. Pupil dilation was achieved prior to examination via rocuronium topical application. Assessment of fundus by the smartphone was classified as satisfactory, moderately satisfactory, and unsatisfactory. Fundus examination was also performed with a 20D, 30D, or 78D lens for comparison. Pupillary dilation was satisfactory, moderately satisfactory, or absent in 17, 32, and 28 eyes, respectively. Fundus examination with the smartphone-based device was satisfactory, moderately satisfactory, or unsatisfactory in 44, 15, and 18 eyes, respectively. The feasibility of the fundus examination was affected by the form of the globe; by the quality of pupil dilation; by the color of the iris (images could not be obtained from species with an orange, bright iris); and by the species, with owls (Strigiformes) being the easiest to observe. Based on these findings, fundus examination was feasible in most bird species examined in this study.
ABSTRACT
OBJECTIVE: To assess changes in pupil size and intraocular pressure (IOP) following topical application of a 0.5% tropicamide solution in the eyes of healthy butorphanol-sedated dogs. ANIMALS: 12 healthy adult Beagles. PROCEDURES: In a randomized crossover study consisting of 2 treatment periods with a 1-week washout between periods, dogs received an IM injection of butorphanol (0.2 mg/kg) or an equal volume of sterile saline (0.9% NaCl) solution. For each dog, 1 drop of 0.5% tropicamide ophthalmic solution was topically instilled in one eye and 1 drop of artificial tear solution was topically instilled in the other eye 10 minutes after the IM injection and again 5 minutes later. Extent of sedation, pupil size, and IOP were evaluated from 20 minutes before to 80 minutes after the IM injection and compared among treatment combinations. RESULTS: Butorphanol induced mild (n = 9) or moderate (3) sedation in all dogs and slightly delayed the onset of, but did not prevent, tropicamide-induced mydriasis. Butorphanol caused a significant increase in IOP, which was not exacerbated by tropicamide-induced mydriasis; however, that increase was generally not sufficient to exceed the upper limit of the IOP reference range. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that butorphanol did not prevent tropicamide-induced mydriasis but did increase the IOP in ophthalmologically normal Beagles. Although the butorphanol-induced increase in IOP did not appear clinically relevant for the dogs of this study, that may not be true for dogs with glaucoma, and care should be taken when butorphanol is administered to such dogs.
